Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kapil Maithal

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
FEBS Letters|November 19, 2003
Conformational fluctuations in anthrax protective antigen: a possible role of calcium in the folding pathway of the proteinPradeep K Gupta, Harish Chandra, Reetika Gaur, et al.
AMB Express|June 21, 2014
Assessment of packed bed bioreactor systems in the production of viral vaccinesRamya Rajendran, Rajendra Lingala, Siva Kumar Vuppu, et al.
Biochimica Et Biophysica Acta|February 9, 2005
Proteome analysis of mouse macrophages treated with anthrax lethal toxinHarish Chandra, Pradeep K Gupta, Kirti Sharma, et al.
Parasitology|February 20, 2016
Anamnestic responses in pigs to the Taenia solium TSOL18 vaccine and implications for control strategiesMarshall W Lightowlers, Meritxell Donadeu, M Elaiyaraja, et al.
Indian Pediatrics|March 29, 2022
Long-term Persistence of Immunogenicity After Primary Vaccination and Response to Booster Vaccination With Typhoid Conjugate Vaccine: Results of a Phase IV Extension StudyAmbrose Kumar Kandulna, Kheya Ghosh Uttam, Shrikant Sharma, et al.
The Journal of Biological Chemistry|December 8, 2019
Withdrawal: Nuclear localization and <i>in situ</i> DNA damage by <i>Mycobacterium tuberculosis</i> nucleoside-diphosphate kinaseAdesh Kumar Saini, Kapil Maithal, Prem Chand, et al.
The Journal of Biological Chemistry|September 21, 2004
Nuclear localization and in situ DNA damage by Mycobacterium tuberculosis nucleoside-diphosphate kinaseAdesh Kumar Saini, Kapil Maithal, Prem Chand, et al.
Eclinicalmedicine|July 26, 2021
Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): Results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in healthy subjects in IndiaTaufik Momin, Kevinkumar Kansagra, Hardik Patel, et al.
Vaccine|June 14, 2021
Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal modelsAyan Dey, T M Chozhavel Rajanathan, Harish Chandra, et al.
Human Vaccines & Immunotherapeutics|August 26, 2025
An active post-marketing surveillance study to evaluate the safety and immunogenicity of Zyvac TCV in healthy participantsSanjay Vasant Mankar, Chintan Patel, Abhishek Chavan, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
FEBS Letters|November 19, 2003
Conformational fluctuations in anthrax protective antigen: a possible role of calcium in the folding pathway of the proteinPradeep K Gupta, Harish Chandra, Reetika Gaur, et al.
AMB Express|June 21, 2014
Assessment of packed bed bioreactor systems in the production of viral vaccinesRamya Rajendran, Rajendra Lingala, Siva Kumar Vuppu, et al.
Biochimica Et Biophysica Acta|February 9, 2005
Proteome analysis of mouse macrophages treated with anthrax lethal toxinHarish Chandra, Pradeep K Gupta, Kirti Sharma, et al.
Parasitology|February 20, 2016
Anamnestic responses in pigs to the Taenia solium TSOL18 vaccine and implications for control strategiesMarshall W Lightowlers, Meritxell Donadeu, M Elaiyaraja, et al.
Indian Pediatrics|March 29, 2022
Long-term Persistence of Immunogenicity After Primary Vaccination and Response to Booster Vaccination With Typhoid Conjugate Vaccine: Results of a Phase IV Extension StudyAmbrose Kumar Kandulna, Kheya Ghosh Uttam, Shrikant Sharma, et al.
The Journal of Biological Chemistry|December 8, 2019
Withdrawal: Nuclear localization and <i>in situ</i> DNA damage by <i>Mycobacterium tuberculosis</i> nucleoside-diphosphate kinaseAdesh Kumar Saini, Kapil Maithal, Prem Chand, et al.
The Journal of Biological Chemistry|September 21, 2004
Nuclear localization and in situ DNA damage by Mycobacterium tuberculosis nucleoside-diphosphate kinaseAdesh Kumar Saini, Kapil Maithal, Prem Chand, et al.
Eclinicalmedicine|July 26, 2021
Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): Results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in healthy subjects in IndiaTaufik Momin, Kevinkumar Kansagra, Hardik Patel, et al.
Vaccine|June 14, 2021
Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal modelsAyan Dey, T M Chozhavel Rajanathan, Harish Chandra, et al.
Human Vaccines & Immunotherapeutics|August 26, 2025
An active post-marketing surveillance study to evaluate the safety and immunogenicity of Zyvac TCV in healthy participantsSanjay Vasant Mankar, Chintan Patel, Abhishek Chavan, et al.
Pageof 3